Startup aimed to develop global tools that help scientists move faster and better in their research work. We want to change the world of oncological research
2 INTEROPERABILIDAD
La piedra angular de la experiencia del paciente
@lmezama, CEO de @cancerappy: "Igual que donamos órganos para la ciencia, tendríamos que
empezar a pensar en donar los datos para la ciencia."
https://t.co/8T67NPdBU4
🩺📲Terminamos la velada con "Fireside Chat: Acelerando el cambio".
Intervienen @pedrodiazyuste (Director de Salud Digital de MAPFRE), @lmezama (CEO de @cancerappy) y Miguel A. Bru Angelats (Vice Presidente de Desarrollo de Negocio de @madeofgenes). ¡Modera @LuisaBautistaG!
#cancer is a global problem and the identification of novel targets urgent need. In cancerappy we help scientists and researchers to improve their work developing tools that combine artificial intelligence and science.
🚀#2 Startup- #dhws21@4YFN_MWC🚀
@lmezama pitching @cancerappy, the #ArtificialIntelligence platform for biomarkers, drug development and personalised medicine💊 which aims to fill the gap between basic data and pharma intelligence tools.
📢 La Ministra de Industria @mincoturgob, @MarotoReyes, ha visitado esta mañana #Spain4YFN21, la delegación española de #startups organizada por @redpuntoes e @ICEX_
¡Ven a conocer a las 29 empresas expositoras!
We're proud to announce that @lmezama from @cancerappy will be speaking at the @4YFN_MWC -#DHWS21.
He'll take part in the "Start-up pitches & shark tank" at 16:45 CET🕐-
To learn more about the summit, visit👇
https://t.co/c2206LA7TX
We started a new stage of cancerappy with new professionals in the team and with a new office in @deustoEmprende. Very proud of our team and with the belief that good work will guide our future. #ArtificialIntelligence